Kevin Warsh Takes Helm at Federal Reserve Markets Eye Policy Shift Amid Inflation and Geopolitical Risks SpaceX Launches Upgraded Starship V3 in 12th Test Flight as Company Plans Public Listing Autodesk Poised for Q1 Earnings Beat with Steady Outlook Fed Minutes Signal Potential Rate Hikes if Iran Conflict Sustains Inflationary Pressures Plus500 Reports 11 Quarterly Revenue Increase Expects to Meet Market Expectations WMO Report Warns Global Temperatures May Stay Near Record Highs Through 2030 Raising El Nio Risks CHRW Q1 2026 Earnings EPS Surpasses Estimates Amid Mixed Market Signals GIPR Q1 2026 Earnings NarrowerThanExpected Loss Fails to Avert Stock Decline STKS Q1 2026 Earnings Widening Losses as EPS Misses Estimates by 146 AVY Q1 2026 Earnings EPS Beats Estimates Stock Edges Higher Tucows Inc TCX Q1 2026 Earnings Negative EPS Reflects Ongoing Investment Phase Amid Stock Stagnation Vanda Pharmaceuticals Q1 2026 Earnings EPS Misses Estimates Stock Advances Despite Wider Loss Artius II Acquisition Inc AACB Holds Steady Near NAV as Market Awaits Business Combination Royalty Pharma RPRX Holds Ground Near Midpoint Steady Trading in Tight Range VAALCO Energy EGY Slips 15 as Energy Sector Faces Headwinds Key Support Levels in Focus L3Harris Technologies LHX Edges Lower Amid Sector Rotation Key Levels in Focus CHS Inc CHSCM Holds Steady Near Support as Price Action Remains RangeBound IBMs Quantum Leap 27 Billion Market Cap Surge After Federal Quantum Computing Investment DNN Q1 2026 Earnings Widerthanexpected loss as uranium development costs mount Natera NTRA Holds Near 203 Modest Decline Signals Cautious Consolidation Hershey HSY Surges 35 as Confectionary Giant Tests Resistance Zone Gauzy Ltd GAUZ Slides Further as Shares Test Key Support Level NEWTH Senior Notes Drift Lower as FixedIncome Investors Weigh Yield Stability Green Brick Partners GRBK Gains 122 as Homebuilder Approaches Key Resistance Greenlight Capital Re Ltd GLRE Holds Steady Near Resistance as Reinsurance Sector Faces Mixed Signals Genuine Parts Company GPC Edges Lower as It Tests Key Support Zone Inhibikase Therapeutics IKT Recovers 35 as Buyers Defend Key Support Level